X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Divis Laboratories - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs DIVIS LABORATORIES - Comparison Results

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES DIVIS LABORATORIES ALKEM LABORATORIES/
DIVIS LABORATORIES
 
P/E (TTM) x - 19.3 - View Chart
P/BV x 6.1 4.2 144.8% View Chart
Dividend Yield % 0.7 1.5 48.3%  

Financials

 ALKEM LABORATORIES   DIVIS LABORATORIES
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
DIVIS LABORATORIES
Mar-16
ALKEM LABORATORIES/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,5892,484 64.0%   
Low Rs1,232918 134.2%   
Sales per share (Unadj.) Rs417.5142.3 293.5%  
Earnings per share (Unadj.) Rs56.341.9 134.4%  
Cash flow per share (Unadj.) Rs64.746.3 139.7%  
Dividends per share (Unadj.) Rs12.7010.00 127.0%  
Dividend yield (eoy) %0.90.6 153.1%  
Book value per share (Unadj.) Rs292.9161.5 181.4%  
Shares outstanding (eoy) m119.57265.47 45.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.412.0 28.3%   
Avg P/E ratio x25.140.6 61.7%  
P/CF ratio (eoy) x21.836.7 59.4%  
Price / Book Value ratio x4.810.5 45.7%  
Dividend payout %22.623.9 94.5%   
Avg Mkt Cap Rs m168,653451,525 37.4%   
No. of employees `000NA3.7 0.0%   
Total wages/salary Rs m9,1713,649 251.3%   
Avg. sales/employee Rs ThNM10,184.4-  
Avg. wages/employee Rs ThNM984.1-  
Avg. net profit/employee Rs ThNM2,998.5-  
INCOME DATA
Net Sales Rs m49,91537,764 132.2%  
Other income Rs m1,645848 193.9%   
Total revenues Rs m51,56138,612 133.5%   
Gross profit Rs m8,48214,138 60.0%  
Depreciation Rs m1,0061,182 85.1%   
Interest Rs m67123 2,890.5%   
Profit before tax Rs m8,45113,781 61.3%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6062,662 60.3%   
Profit after tax Rs m6,73111,119 60.5%  
Gross profit margin %17.037.4 45.4%  
Effective tax rate %19.019.3 98.4%   
Net profit margin %13.529.4 45.8%  
BALANCE SHEET DATA
Current assets Rs m27,06230,947 87.4%   
Current liabilities Rs m15,3245,195 295.0%   
Net working cap to sales %23.568.2 34.5%  
Current ratio x1.86.0 29.6%  
Inventory Days Days67117 57.0%  
Debtors Days Days4185 48.5%  
Net fixed assets Rs m12,61017,027 74.1%   
Share capital Rs m239531 45.0%   
"Free" reserves Rs m34,49042,341 81.5%   
Net worth Rs m35,02742,877 81.7%   
Long term debt Rs m1,2125 25,778.7%   
Total assets Rs m54,38749,684 109.5%  
Interest coverage x13.6595.0 2.3%   
Debt to equity ratio x00 31,556.5%  
Sales to assets ratio x0.90.8 120.8%   
Return on assets %13.622.4 60.7%  
Return on equity %19.225.9 74.1%  
Return on capital %24.932.2 77.2%  
Exports to sales %12.985.3 15.2%   
Imports to sales %3.122.9 13.5%   
Exports (fob) Rs m6,46132,198 20.1%   
Imports (cif) Rs m1,5408,654 17.8%   
Fx inflow Rs m6,56332,270 20.3%   
Fx outflow Rs m3,0128,775 34.3%   
Net fx Rs m3,55223,496 15.1%   
CASH FLOW
From Operations Rs m7,25910,379 69.9%  
From Investments Rs m1,864-4,135 -45.1%  
From Financial Activity Rs m-9,273-6,241 148.6%  
Net Cashflow Rs m-1503 -4,545.5%  

Share Holding

Indian Promoters % 66.9 52.0 128.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 11.8 280.5%  
FIIs % 0.0 19.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 17.2 -  
Shareholders   68,381 31,796 215.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   ABBOTT INDIA  NATCO PHARMA  AJANTA PHARMA  PFIZER  ALEMBIC PHARMA  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Lupin up 4%(01:30 pm)

After opening the day flat, share markets in India remained rangebound and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 24, 2017 03:36 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS